Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mitsuko Ichimura is active.

Publication


Featured researches published by Mitsuko Ichimura.


Pancreas | 2001

Study on free radicals and pancreatic fibrosis-pancreatic fibrosis induced by repeated injections of superoxide dismutase inhibitor

Naoki Matsumura; Koji Ochi; Mitsuko Ichimura; Takaaki Mizushima; Hideo Harada; Mine Harada

The exact mechanisms of the development of pancreatic fibrosis are still unknown. To clarify the relationship between pancreatic fibrosis and free radicals, the effect of the administration of a superoxide dismutase (SOD) inhibitor, diethyldithiocarbamate (DDC), on pancreatic fibrosis in rats was studied. A single intraperitoneal injection of 500 mg/kg of DDC significantly reduced SOD activity and significantly increased lipid peroxidation products in the pancreas, showing no histologic changes of inflammation or necrosis. Repeated administration of 500 mg/kg DDC, twice a week, caused inter-and intralobular fibrosis with atrophy of acinar cells in the pancreas for at least 2 weeks without fibrosis of the liver and kidney. Administration of allopurinol showed preventive effects against DDC-induced pancreatic fibrosis. In conclusion, repeated administration of DDC, which caused pancreatic fibrosis, is a new experimental model of pancreatic fibrosis from the viewpoint of oxidative stress.


Pancreas | 2002

Matrix metalloproteinase-2 in pancreatic juice for diagnosis of pancreatic cancer

Motohiro Yokoyama; Koji Ochi; Mitsuko Ichimura; Takaaki Mizushima; Toshiyuki Shinji; Norio Koide; Tetsuya Tsurumi; Hideaki Hasuoka; Mine Harada

Introduction Matrix metalloproteinase-2 (MMP-2) has an activity to degrade type IV collagen and is associated with invasion angiogenesis of malignant tumor. Aim A diagnostic value of MMP-2 in pancreatic juice was studied in the diagnosis of pancreatic cancer. Methodology Using gelatin zymography, active MMP-2 and proMMP-2 were determined in pancreatic juice obtained endoscopically from 12 patients with pancreatic cancer, 11 with chronic pancreatitis, and 7 control subjects. Results ProMMP-2 was detected in 12 of 12 patients (100%) with pancreatic cancer, 6 of 11 (54.5%) with chronic pancreatitis, and 3 of 7 (42.9%) controls. Active MMP-2 was detected in 11 patients (91.6%) with pancreatic cancer, 2 (18.2%) with chronic pancreatitis, and none of the control subjects. An activation ratio of MMP-2 (active MMP-2/total MMP-2) in pancreatic juice is significantly higher in pancreatic cancer (23.4 ± 4.4%, mean ± SE) than in chronic pancreatitis (2.1 ± 1.7%) and controls (0%) (p < 0.01). Active MMP-2 was also detected in pancreatic juice from three cases of small pancreatic cancer (tumor <2 cm in diameter). Conclusion Our observation suggests that detection of active MMP-2 in pancreatic juice using gelatin zymography may be useful for the diagnosis of pancreatic cancer.


Journal of Gastroenterology and Hepatology | 2005

Camostat, an oral trypsin inhibitor, reduces pancreatic fibrosis induced by repeated administration of a superoxide dismutase inhibitor in rats

Yasuyuki Emori; Takaaki Mizushima; Naoki Matsumura; Koji Ochi; Hiroaki Tanioka; Akinori Shirahige; Mitsuko Ichimura; Toshiyuki Shinji; Norio Koide; Mitsune Tanimoto

Background and Aim:  An oral trypsin inhibitor, camostat (CM), has a beneficial effect on chronic pancreatitis, but its mechanism is not yet fully understood. Recently, pancreatic stellate cells (PSC) have been reported to play an essential role in pancreatic fibrosis. An experimental model of pancreatic fibrosis induced by a superoxide dismutase (SOD) inhibitor (diethyldithiocarbamate [DDC]) was developed in rats. Thus, the effect of an oral trypsin inhibitor on pancreatic fibrosis and PSC was investigated.


International Journal of Pancreatology | 1998

Prevention of hyperlipidemic acute pancreatitis during pregnancy with medium-chain triglyceride nutritional support

Takaaki Mizushima; Koji Ochi; Naoki Matsumura; Mitsuko Ichimura; Tadaaki Ishibashi; Keiich Tsuboi; Hideo Harada

SummaryConclusionA combination of diet therapy, nutritional support with medium-chain triglycerides (MCT), and well-planned preterm Cesarean delivery on demand is an effective measure to prevent gestational hyperlipidemic pancreatitis and leads to successful childbirth.BackgroundPrevention and therapy of gestational hyperlipidemic pancreatitis are important, although difficult, because the condition carries a high maternal and fetal morbidity and mortality.ResultsWe describe a 32-yr-old female with lipoprotein lipase-deficient familial hypertriglyceridemia who had recurrent episodes of acute pancreatitis. The third episode occurred with worsened hyperlipidemia 7 yr earlier at 32 wk of her first pregnancy and resulted in fetal death. The fourth and fifth episodes were also accompanied by marked hyperlipidemia probably caused by drug discontinuance and dietary noncompliance. She became pregnant. Serum triglyceride levels were controlled below 2000 mg/dL by strict monitoring with low-fat, low-calorie diet and MCT nutritional support. A premature but healthy infant was born by Cesarean delivery at 36 wk of gestation when the mother presented with mild abdominal pain and was found to have uterine contractions. The ensuing clinical course has been uneventful.


Biotechnology and Applied Biochemistry | 1999

Purification and characterization of alkaline phosphatase from Bacillus stearothermophilus.

Shuji Mori; Motoi Okamoto; Masahiro Nishibori; Mitsuko Ichimura; Junko Sakiyama; Hiroshi Endo

Soluble alkaline phosphatase from the thermophilic bacterium Bacillus stearothermophilus was purified by a combination of chromatographic methods, and its properties were examined. The purified enzyme had specific activity of 4.43 μmol p‐nitrophenol/min per mg of protein and seemed to be a single band on SDS/PAGE with a molecular mass of 32 kDa. Its apparent Km for p‐nitrophenyl phosphate was 1.114 mM. The enzyme exhibited an optimal pH of approx. 9.0 and exhibited its highest activity at 60–70 °C. It also showed a bivalent cation requirement for activity, with maximal enhancement in the presence of Mg2+. In addition, significant thermal stability was observed in comparison with counterparts from mesophiles. Its partial N‐terminal sequence was T1FSIVAFDPATGELGIAVQ19 as estimated by automated Edman degradation method. A search on the SwissProt database did not reveal any similar protein sequences from other sources.


Journal of Gastroenterology and Hepatology | 2004

Pancreatic enzyme supplement improves dysmotility in chronic pancreatitis patients

Takaaki Mizushima; Koji Ochi; Mitsuko Ichimura; Katsuyuki Kiura; Hideo Harada; Norio Koide

Background and Aims:  Impaired gallbladder contraction and rapid gastric emptying in patients with chronic pancreatitis may be the result of depleted pancreatic exocrine function. The authors tested whether oral pancreatic enzymes can improve the dysmotility or not.


Journal of Gastroenterology and Hepatology | 2006

Xanthine oxidase-derived free radicals directly activate rat pancreatic stellate cells.

Hiroaki Tanioka; Takaaki Mizushima; Akinori Shirahige; Koki Matsushita; Koji Ochi; Mitsuko Ichimura; Naoki Matsumura; Toshiyuki Shinji; Mitsune Tanimoto; Norio Koide

Background and Aim:  Free radicals are reported to be associated with fibrosis in the pancreas. It is generally accepted that pancreatic stellate cells (PSC) play an important role in pancreatic fibrosis. However, the exact role of free radicals in activation of PSC has not been fully elucidated. In the present study, using a superoxide dismutase (SOD) inhibitor, diethyldithiocarbamate (DDC) with cultured PSC, we investigated how free radicals act on the activation of PSC.


Journal of Gastroenterology and Hepatology | 2008

Oral administration of taurine improves experimental pancreatic fibrosis

Akinori Shirahige; Takaaki Mizushima; Koki Matsushita; Kiminari Sawa; Koji Ochi; Mitsuko Ichimura; Hiroaki Tanioka; Toshiyuki Shinji; Norio Koide; Mitsune Tanimoto

Background and Aim:  The mechanism of pancreatic fibrosis is unclear. Taurine is used in the clinical treatment of a wide variety of diseases, but its effect on improving pancreatic fibrosis is unknown. We examined whether a diet with added taurine improves pancreatic fibrosis induced by dibutyltin dichloride (DBTC) in an experimental chronic pancreatitis rat model. In addition, we examined the influence of taurine on pancreatic stellate cells.


Gastroenterology | 2001

Pancreatic fibrosis induced by repeated injections of an SOD inhibitor

Naoki Matsumura; Koji Ochi; Mitsuko Ichimura; Motohiro Yokoyama; Toshiyuki Shinji; Norio Koide; Tetsuya Tsurumi; Hideaki Hasuoka; Hideo Harada


岡大三朝分院研究報告 | 2001

Matrix metalloproteinases (MMPs) and pancreatic diseases

Motohiro Yokoyama; Koji Ochi; Takaaki Mizushima; Mitsuko Ichimura; Tetsuya Tsurumi; Fumihiro Mitsunobu; Yoshiro Tanizaki

Collaboration


Dive into the Mitsuko Ichimura's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge